Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors
Journal article published in 2011 by
M. H. G. Langenberg,
P. O. Witteveen,
J. M. L. Roodhart,
M. P. Lolkema,
H. M. W. Verheul 
,
M. Mergui Roelvink,
E. Brendel,
J. Krätzschmar,
B. Loembé,
A. Nol Boekel,
O. Christensen,
J. H. M. Schellens,
E. E. Voest
,
M. Mergui Roelvink,
E. Brendel,
J. Krätzschmar,
B. Loembé,
A. Nol Boekel,
O. Christensen,
J. H. M. Schellens,
E. E. Voest
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 